Showing results (21-30 of 57) with videos related to
Sort By:
Pageof 6
Circulation Research|June 1, 1975
Pressure drop across artificially induced stenoses in the femoral arteries of dogsD F Young, N R Cholvin, A C RothBiomedical Sciences Instrumentation|January 1, 1994
Development of a direct systolic cardiac augmentation deviceB C Frake, D F Young, R K KudejThe Journal of General Virology|October 1, 1988
Immunization with solid matrix-antibody-antigen complexes containing surface or internal virus structural proteins protects mice from infection with the paramyxovirus, simian virus 5R E Randall, D F Young, J A SouthernNeurology|January 1, 1985
The natural history of lumbosacral plexopathy in cancerK A Jaeckle, D F Young, K M FoleyThe New England Journal of Medicine|July 24, 1975
Methotrexate: distribution in cerebrospinal fluid after intravenous, ventricular and lumbar injectionsW R Shapiro, D F Young, B M MehtaAnnals of Neurology|November 1, 1983
Diffuse bone marrow metastasis by glioblastoma: premortem diagnosis by peroxidase-antiperoxidase staining for glial fibrillary acidic proteinW K Yung, S J Tepper, D F YoungBiomedical Sciences Instrumentation|January 1, 1989
Microcomputer-based analyzer for the assessment of Doppler ultrasound blood velocity waveformsL R Waite, D F Young, S P FordJournal of Virology|February 12, 2002
Degradation of STAT1 and STAT2 by the V proteins of simian virus 5 and human parainfluenza virus type 2, respectively: consequences for virus replication in the presence of alpha/beta and gamma interferonsJ Andrejeva, D F Young, S Goodbourn, et al.Virology|February 7, 2001
Paramyxoviridae use distinct virus-specific mechanisms to circumvent the interferon responseD F Young, L Didcock, S Goodbourn, et al.Journal of Virology|November 13, 1999
The V protein of simian virus 5 inhibits interferon signalling by targeting STAT1 for proteasome-mediated degradationL Didcock, D F Young, S Goodbourn, et al.Pageof 6